Clinical Research

Clinical Trials Drug Development Drug Efficacy Randomized Controlled Trials Patient Outcomes Studies Observational Studies Drug Trials Patient Studies Preclinical Studies

PhotoTat Lets Tattoos Switch Between Hidden and Vivid States

If proven safe, the inks could let clinic marks stay invisible until a doctor activates them.

FDA Expands Remibrutinib Label to Treat Symptomatic Dermographism

Common SERPINE1 Variant Changes Airway Response to Mepolizumab in Children

AI-Driven Analysis Links BRSK1 Variants to New Neurodevelopmental Syndrome

Lilly’s Foundayo Wins Early Market Share as Company Moves to Scale Production

Kissick Foundation and Milken Institute Award $2.5 Million for Sporadic FTD Research

Study Finds Neuromuscular Junction Failure Drives Age-Related Muscle Weakness

Amgen’s Dazodalibep Meets Primary Goal in Phase 3 Sjögren’s Trial

RNA Therapy Enhances Fat Loss and Preserves Muscle in Mice When Paired With Semaglutide

Two Orbitofrontal Patches Predict Risky Versus Avoidant Choices

Definium’s LSD-Based Therapy Posts Third Positive Phase 3 Result in GAD

Proteomic Signatures in Children Predict Adult Cardiometabolic and Kidney Disease Risk

ADHD Linked to Markedly Higher Rates of Gastrointestinal Problems

Lasker Awards Honor Orexin Discoverers, Hemophilia Antibody Team and Michael J. Fox

Study Ties Higher Blood Xylitol to Increased Long‑Term Heart Risk

Psilocybin Prevents Chemotherapy Nerve Damage in Mice

DRC Ebola Outbreak Surpasses 3,000 Deaths as Response Strains Resources

Bengaluru Cancellation Exposes Risky DIY Peptide Trend

One-Year High‑Intensity Exercise Cuts Atrial Fibrillation Time by Nearly Half

Milvexian Fails to Cut Heart Attack, Stroke or Death After Acute Coronary Syndrome